BioSpace News Archive

Quest Diagnostics announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share, payable on October 22, 2018 to shareholders of record of Quest Diagnostics common stock on October 5, 2018.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for EYLEA® (aflibercept) Injection in patients with wet age-related macular degeneration (wet AMD).

Leading non-medical home care franchise listed among 5000 fastest-growing privately held companies in the U.S.

n alarming number of Americans are unclear whether their health insurance works outside the US, according to a new survey from InsureMyTrip.

Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that it was awarded an Other Transaction Agreement (OTA) to support the Joint Project Manager Medical Countermeasure Systems (JPM-MCS), a component of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO CBRND) for advanced biologics manufacturing services—specifically, to manufacture an anti-Ebola monoclonal antibody (mAb).

ITUS Corporation announced that CEO, Dr. Amit Kumar, will be presenting at the Next Generation Dx Summit in Washington, D.C., being held on August 20th-24th.

Healthy Interactions, a global leader in health education, in collaboration with Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the launch of map4health™ - a digital platform and mobile application in the U.S. that was designed to help facilitate and enhance communications between diabetes patients and educators.

Flora Inc. is pleased to announce that living a healthy life might just win you a Tesla, thanks to the Win Thomas’ Tesla Sweepstakes presented by Flora, running now until December 31, 2018.

CEL-SCI Corporation announces that the NYSE American (the “Exchange”) has accepted the Company’s plan to bring itself into compliance with the Exchange’s continued listing standards.

AADE Conference -- Smart Meter, an innovative diabetes management data, technology and solutions company, today announced a poster presentation, The Benefits of Remote Monitoring of Real Time Blood Glucose Data Using iGlucose® System in Managing Patients with Diabetes,